comparemela.com

Latest Breaking News On - Colin kellaher - Page 1 : comparemela.com

Bristol Myers Gets FDA OK of Breyanzi in Follicular Lymphoma

By Colin Kellaher Bristol Myers Squibb has won U.S. Food and Drug Administration expanded approval of its CAR-T cell therapy Breyanzi for adults with relapsed or refractory follicular lymphoma.

Colin kellaherBristol myers squibbDrug administrationMyers squibbDow jones

Inflation Cools as Core Prices Post Smallest Increase Since 2021

Inflation Cools as Core Prices Post Smallest Increase Since 2021 By Vicky Ge Huang U.S. inflation moderated slightly in April, with a key measure of price pressures slowing to its lowest level. -May 16, 2024 at 07:18 am EDT - MarketScreener

New yorkUnited statesMark hamrickMiriam mukuruFabiana negrin ochoaKosaku nariokaColin kellaherMegumi fujikawaPaul hannonAssociation of american railroadsLabor departmentBoston collegeEuropean central bankResearch us high yield bond marketTreasury departmentInflation cools

Eli Lilly Says Once-Weekly Insulin Meets Key Goal in Two Studies

By Colin Kellaher Eli Lilly on Thursday said a pair of late-stage studies of its proposed once-weekly insulin efsitora alfa met their primary endpoints. The Indianapolis drugmaker said.

Colin kellaherEli lillyDow jones

Johnson & Johnson Strikes $850 Million Deal to Boost Dermatology Portfolio

By Colin Kellaher Johnson & Johnson has agreed to buy privately-held biotechnology company Proteologix for an initial $850 million in cash in a deal that bolsters the healthcare giant s.

Colin kellaherNew brunswickDow jones

Eli Lilly Ethics/Compliance Chief Alonzo Weems to Retire

Eli Lilly Ethics/Compliance Chief Alonzo Weems to Retire
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Colin kellaherEli lillyAlonzo weemsDow jones

vimarsana © 2020. All Rights Reserved.